Compass Pathways: Independent Media Talks Psychedelic Medicine
Description
In this episode of Divergent States, we sit down with Kabir Nath, CEO of Compass Pathways, and Dr. Steve Levine, Chief Patient Officer, to talk about the future of psychedelic medicine. From FDA approval and insurance coverage to patient access, cultural safety, and patents, we dig into whether Compass is truly disrupting the pharma model or just reinventing it.
We also share a major community update: the official Divergent States Discord is now open to all of r/Psychonaut. Built by Brady and the mod team, the server is a space for harm reduction, trip reports, deep dives, and authentic connection across the psychedelic movement.
As always, this conversation is about asking the real questions without corporate PR filters. What Compass shared β and what they left unsaid β reveals as much about the future of psilocybin therapy as the answers themselves.
π Join the movement: connect on Discord, support independent media on Patreon, and be part of the conversation.Β
https://discord.gg/swPwT6ZYun
Key Points
- FDA approval: path to affordability or illusion of access?
- COM360 psilocybin therapy: synthetic model, patient journey, and therapy debate
- Access & equity: insurance hurdles, pricing models, and patient foundations
- Cultural safety: trauma-informed design, marginalized populations, indigenous roots
- Patents & Pharma tension: innovation vs. corporate control in psychedelic medicine
- Community news: Divergent States Discord officially launches for r/Psychonaut
Chapters
Β 00:00 β Intro: Setting the frame for Compass Pathways
Β 01:30 β Community Update: Divergent States Discord opens for r/Psychonaut
Β 09:30 β Guest Intros: Kabir Nath & Dr. Steve Levine of Compass Pathways
Β 11:20 β Kabir on moving from pharma to psychedelics
Β 12:30 β Steve on ketamine clinics & new models of care
Β 14:15 β What βsuccessβ looks like for patients
Β 16:00 β COM360 psilocybin therapy: synthetic vs. natural & the role of therapy
Β 17:30 β How Compass plans to deliver psilocybin in different care settings
Β 18:40 β Patient hopes, fears, and the path to access
Β 20:00 β FDA approval, insurance, and affordability
Β 21:00 β Cultural safety, trauma-informed design, and community input
Β 21:45 β Indigenous engagement & staying βin their laneβ
Β 24:15 β The next 5β10 years of psychedelic treatment
Β 26:10 β What could derail psychedelic medicineβs promise
Β 28:10 β Compassβ place in the broader psychedelic ecosystem
Β 29:50 β Outro: Independent media reflections & listener call to actionΒ
New Music from Sndbagz - check out his new EP "Chosen Path" on Soundcloud and Spotify
DIVERGENTS10
Zendo Project
Our listeners get 10% off the Zendo Project SIT Program with the code DIVERGENTS10
Follow and subscribe!
Download the app or text/call 62-FIRESIDE
Our listeners get 10% off the Zendo Project SIT Program with the code DIVERGENTS10
Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.
Special Thanks to our Macrodosers, Super D and Mycocosm, and our Heroic Doser Lucy on Patreon!
Use our code to get 10% off of Zendo Sit Training
DIVERGENTS10























